(AKE) Arkema - Ratings and Ratios

Exchange: PA • Country: France • Currency: EUR • Type: Common Stock • ISIN: FR0010313833

AKE: Adhesives, Coatings, Sealants, Polymers, Additives

Arkema S.A., a global leader in specialty materials, operates across Europe, the Americas, Asia, and internationally. The company is structured into three main segments: Adhesive Solutions, Advanced Materials and Coating Solutions, and Intermediates. The Adhesive Solutions segment offers a diverse range of products, including sealants, flooring adhesives, and waterproofing systems, catering to construction, automotive, and packaging industries. It also provides high-performance polymers such as polyamides and fluorospecialties, along with additives like surfactants and peroxides. The Advanced Materials and Coating Solutions segment specializes in acrylics, photocure resins, and rheology additives, serving markets like electronics, 3D printing, and water treatment. The Intermediates segment produces fluorogases and acrylics, used in applications such as refrigeration and oil extraction. Established in 2003, Arkema is headquartered in Colombes, France, and is recognized for its innovative chemical solutions.

Based on the provided data, Arkemas stock (Ticker: AKE) is trading at €66.00 with a market cap of €4,634.94M. The P/E ratio of 13.66 indicates moderate valuation, while the forward P/E of 7.76 suggests potential undervaluation. The price-to-book ratio of 0.62 reflects a discount relative to its book value. The average 20-day volume is 235,875 shares, with a last price of €66.00. The SMA-20, SMA-50, and SMA-200 are €64.93, €74.19, and €77.83, respectively, indicating a recent downward trend. The ATR of 2.93 suggests moderate volatility.

Over the next three months, technical indicators suggest potential weakness. The stock price is below the SMA-50 and SMA-200, indicating a bearish trend. The ATR of 2.93 implies moderate volatility, with potential price fluctuations between €63.07 and €68.93. Fundamentally, the forward P/E of 7.76 suggests the market may be pricing in future earnings growth, which could support a rebound if realized. The P/B ratio of 0.62 indicates undervaluation relative to book value, which may attract value investors. Overall, the stock is likely to remain range-bound with a slight downside bias.

Additional Sources for AKE Stock

Tweets: X Stocktwits
Fund Manager Positions: Dataroma Stockcircle

AKE Stock Overview

Market Cap in USD 5,694m
Sector Basic Materials
Industry Specialty Chemicals
GiC Sub-Industry Diversified Chemicals
IPO / Inception

AKE Stock Ratings

Growth Rating -19.4
Fundamental -1.25
Dividend Rating 92.6
Rel. Strength -27.2
Analysts -
Fair Price Momentum 65.12 EUR
Fair Price DCF 97.13 EUR

AKE Dividends

Dividend Yield 12m 9.75%
Yield on Cost 5y 11.03%
Annual Growth 5y 9.73%
Payout Consistency 97.2%

AKE Growth Ratios

Growth Correlation 3m -80.8%
Growth Correlation 12m -74.4%
Growth Correlation 5y -16.3%
CAGR 5y 0.37%
CAGR/Max DD 5y 0.01
Sharpe Ratio 12m -0.63
Alpha -39.15
Beta 0.589
Volatility 39.26%
Current Volume 223.9k
Average Volume 20d 208.3k
What is the price of AKE stocks?
As of May 10, 2025, the stock is trading at EUR 65.60 with a total of 223,867 shares traded.
Over the past week, the price has changed by -1.94%, over one month by +5.13%, over three months by -17.79% and over the past year by -30.98%.
Is Arkema a good stock to buy?
Neither. Based on ValueRay Fundamental Analyses, Arkema is currently (May 2025) neither a good nor a bad stock to buy. It has a ValueRay Fundamental Rating of -1.25 and therefor a neutral outlook according to the companies health.
Based on ValueRays Analyses, Dividends and Discounted-Cash-Flow, the Fair Value of AKE as of May 2025 is 65.12. This means that AKE is currently overvalued and has a potential downside of -0.73%.
Is AKE a buy, sell or hold?
Arkema has no consensus analysts rating.
What are the forecast for AKE stock price target?
According to ValueRays Forecast Model, AKE Arkema will be worth about 70.3 in May 2026. The stock is currently trading at 65.60. This means that the stock has a potential upside of +7.21%.
Issuer Forecast Upside
Wallstreet Target Price 93.2 42%
Analysts Target Price - -
ValueRay Target Price 70.3 7.2%